Patent · US Active

Bacteria engineered to treat metabolic diseases

US11896627B2 · kind B2 · utility

0Cited by

21References

22Claims

0Family size

Assignee

Synlogic Operating Company, Inc. · US

Inventors

Dean Falb · Sherborn, US
Vincent M. Isabella · Medford, US
Jonathan W. Kotula · Somerville, US
Paul F. Miller · Salem, US
Sarah Rowe · Somerville, US
Yves Millet · Newton, US
Adam B. Fisher · Cambridge, US

Key dates

Filing date	Jan 26, 2022
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Feb 12, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of attenuating metabolic diseases are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.